Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations
Open Access
- 16 September 2024
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 59 (12) , 1704-1709
Abstract
Impaired post-thaw CD34 cell (postCD34) viability in autologous haematopoietic stem cell transplant (ASCT) could indicate delayed engraftment where multiple factors might complicate the relationship. Despite of a couple of unconfirmed reports of a negative correlation of platelet concentration with postCD34 viability, how platelets might be involved in the relationship is largely unknown. Therefore, this question was addressed in this retrospective study of 82 ASCT patients with a total of 150 collections of peripheral blood stem cells in New Zealand. A significant negative correction between platelet concentration and postCD34 recovery (r = −0.18, p = 0.028) was observed overall, but upon further analysis only confirmed in the subset with graft platelets 1500–2000 ×109/L. Importantly, the postCD34 recovery was clearly reduced in the subgroups with either the lowest or the highest platelet concentration. The lowest subgroup was enriched with collections from patients with Hodgkin or non-Hodgkin lymphoma, whereas the highest subgroup from patients with multiple myeloma, both with clearly male preponderance. We hypothesized that graft platelet concentrations probably indicated CD34 cell state (e.g. cell cycle and cell adhesion highly related to platelet functions) that sustained when platelet concentrations were within a niche range but went out of kilter otherwise.Keywords
This publication has 13 references indexed in Scilit:
- Stem-Cell Aging and Pathways to Precancer EvolutionNew England Journal of Medicine, 2023
- A critical assessment of dose effects of post‐thaw CD34 on autologous stem cell transplantation treatment of haematological malignancieseJHaem, 2023
- Factors influencing post-cryopreserved CD34+ cells viability in the harvested products of autologous haematopoietic stem cellsTransfusion Clinique et Biologique, 2022
- Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project teamTransfusion, 2022
- Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantationTransfusion, 2021
- The EBMT Handbook2019
- Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and RecommendationsTransplantation and Cellular Therapy, 2014
- Hematopoietic Stem-Cell TransplantationNew England Journal of Medicine, 2006
- Cell cycle status of CD34+ cells in human fetal bone marrowEarly Human Development, 2001
- The impact of peripheral blood stem cell transplants (PBSCT) on platelet usageTransfusion Science, 1997